Single nucleotide polymorphisms at the tnfaip3/a20 locus and susceptibilitylresistance to inflammatory and autoimmune diseases

Advances in Experimental Medicine and Biology

Volumn 809, Issue , 2014, Pages 163-183

  Mele, Alessandra ^a   Cervantes, Jesus Revuelta ^a   Chien, Victor ^a   Friedman, David ^a   Ferran, Christiane ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3; UBIQUITIN; DNA BINDING PROTEIN; NUCLEAR PROTEIN; SIGNAL PEPTIDE; TNFAIP3 PROTEIN, HUMAN;

ALLELE; AUTOIMMUNE DISEASE; BEHCET DISEASE; CELIAC DISEASE; CHRONIC RHINOSINUSITIS; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; GENE ACTIVATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPE; HUMAN; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULARLY TARGETED THERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSORIASIS; RHEUMATIC HEART DISEASE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; ANIMAL; GENETIC PREDISPOSITION; GENETICS; INFLAMMATION; REVIEW;

ANIMALS; AUTOIMMUNE DISEASES; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84908042420     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0398-6_10     Document Type: Chapter

References (74)

1. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
2. Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol2005; 5:749-59; PMlD:16175180.
3. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
4. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
5. Beg AA, Baldwin AS Jr. The I kappa B proteins: multifunctional regulators of RelINF-kappa B transcription factors. Genes Dev 1993; 7:2064-70; PMlD:8224838; http://dx.doi.orgll0.l1OlIgad.7.11.2064.
6. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
7. Baldwin ASJ Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14:649-83; PMlD:8717528; http://dx.doi.org/1O.1146/annurev.immuno1.14.1.649.
8. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
9. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
10. Mauro C, Pacifico F, Lavorgna A, Mellone S, Iannetti A, Acquaviva R, Formisano S, Vito P, Leonardi A. ABIN-l binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB. 1 Bioi Chern 2006; 281:18482-8; PMlD:16684768; http://dx.doi.org/10.1074/jbc.M601502200.
11. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
12. http://web.ornl.gov/sci/techresources/Human_ Genome/faq/snps.shtm.
13. Small insertions and deletions (INDELs) in human genomes. Hum Mol Genet 2010; 19: 131-6; http://dx.doi.orgll 0.1 093/hmglddq400.
14. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
15. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
16. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
17. Ogino S, Gulley ML, den Dunnen JT, Wilson RB; Association for Molecular Patholpogy Training and Education Committtee. Standard mutation nomenclature in molecular diagnostics: practical and educational challenges. J Mol Diagn 2007; 9: 1-6; PMID: 17251329; http://dx.doi.orgIl0.2353/jmoldx.2007.060081.
18. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-7; PMlD:880 1636; http://dx.doi.org/10.1126/science.273.5281.1516.
19. Boonyasrisawat W, Eberle D, Bacci S, Zhang YY, Nolan D, Gervino EV, Johnstone MT, Trischitta V, Shoelson SE, Doria A. Tag polymorphisms at the A20 (TNFAIP3) locus are associated with lower gene expression and increased risk of coronary artery disease in type 2 diabetes. Diabetes 2007; 56:499-505; PMlD: 17259397; http://dx.doi.orgIl0.2337/db06-0946.
20. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005; 365: 1333-46; PMID: 15823385.
21. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
22. Stamler J, Vaccaro Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16:434-44; PMTD:8432214; http://dx.doi.org/l0.2337/diacare.16.2.434.
23. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
24. , Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, et at. 2010 Rheumatoid arthritis classitication criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62:2569-81; PMTD:20872595; http://dx.doi.orgIl0.l002/art.27584.
25. Consortium TWTCC; Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78; PMTD:17554300; http://dx.doi.org/IO.l038/nature05911.
26. Thomson W, Barton A, Ke X, Eyre S, Hinks A, Bowes J, Donn R, Symmons D, Hider S, Bruce IN. Rheumatoid arthritis association at 6q23. Nat Genet 2007; 39:1431-3; PMID:17982455.
27. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
28. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
29. Plant D, Farragher T, Flynn E, Martin P, Eyre S, Bunn D, Worthington J, Symmons D, Barton A, Thomson W. A genetic marker at the OLTG3/TNF AIP3 locus associates with methotrexate continuation in early inflammatory polyarthritis: results from the Norfolk Arthritis Register. Pharmacogenomics J 2012; 12: 128-33; PMlD:20921970; http://dx.doi.org/10.1038/tpj.2010.80.
30. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
31. Knevel R, de Rooy DP, Gregersen PK, Lindqvist E, Wilson AG, Griindal G, Zhernakova A, van Nies JA, Toes RE, Tsonaka R, et al. Studying associations between variants in TRAF I-C5 and TNF AIP3-0LIG3 and the progression ofjoint destruction in rheumatoid arthritis in multiple cohorts. Ann Rheum Dis 2012; 71:1753-5; PMTD:22586175; http://dx.doi.orgI10.1136/annrheumdis-2012-201289.
32. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
33. Musone SL, Taylor KE, Nititham J, Chu C, Poon A, Liao W, Lam ET, Ma A, Kwok PY, Criswell LA. Sequencing ofTNF AIP3 and association of variants with multiple autoimmune diseases. Genes lmmun 2011; 12:176-82; PMTD:21326317; http://dx.doi.orgI10.1038/gene.2010.64.
34. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
35. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
36. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
37. Rahman A, Isenberg DA. Systemic lupus erythematosus. N EnglJ Med2008; 358:929-39; PMTD: 18305268; http://dx.doi.org/l 0.l 056INEJMra071297.
38. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
39. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
40. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
41. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
42. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
43. Zhong H, Li XL, Li M, Hao LX, Chen RW, Xiang K, Qi XB, Ma RZ, Su B. Replicated associations of TNFAIP3, TNIPI and ETSI with systemic lupus erythematosus in a southwestern Chinese population. Arthritis Res Ther 2011; 13:R 186; PMTD:22087647; http://dx.doi.org/1O.1186/ar3514.
44. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
45. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
46. Adrianto I, Wen F, Templeton A, Wiley G, King JB, Lessard CJ, Bates JS, Hu Y, Kelly JA, Kaufman KM, et al. Association of a functional variant downstream of TNF AIP3 with systemic lupus erythematosus. Nat Genet 2011; 43(3 ):253-8; PMlD:21336280; http://dx.doi.org/10.1038/ng.766.
47. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
48. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. NEngl JMed 1994; 331: 1428-36; PMlD:7969282; http://dx.doi.org/l 0.1 056INEJM1994112433121 07.
49. Cooper JD, Smyth DJ, Smiles AM, Plagnol V, Walker NM, Allen JE, Downes K, Barrett JC, Healy BC, Mychaleckyj JC, et al. Meta-analysis of genome-wide association study data identifies additional type I diabetes risk loci. Nat Genet 2008; 40:1399-401; PMlD:18978792; http://dx.doi.org/IO.1038/ng.249.
50. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
51. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
52. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
53. Naldi L. Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy 2004; 3: 121-8; PMTD: 15180464; http://dx.doi.org/l 0.2174/15680 10043343958.
54. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
55. Tejasvi T, Stuart PE, Chandran V, Voorhees JJ, Gladman DO, Rahman P, Elder n, Nair RP. TNFA1P3 Gene Polymorphisms Are Associated with Response to TNF Blockade in Psoriasis. J Invest Dermatol 2012; 132:593-600; PMTD:22113471; http://dx.doi.org/IO.l038/jid.2011.376.
56. Green PH, Cellier C. Celiac disease. N Engl J Med 2007; 357:1731-43; PMTD:17960014; http://dx.doi. org/l 0.1 056INEJMra071600.
57. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
58. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
59. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
60. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
61. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
62. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
63. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
64. Koumakis E, Giraud M, Dieude P, Cohignac V, Cuomo G, Airo P, Hachulla E, Matucci-Cerinic M, Diot E, Caramaschi P, et al. Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNF AIP3 locus as a risk factor for polyautoimmunity. Arthritis Rheum 2012; 64:2746-52; PMlD:22488580; http://dx.doi.org/l0.l002/art.34490.
65. Yurdakul S, Hamuryndan V, Yazici H. Behyet syndrome. Curr Opin Rheumatol 2004; 16:38-42; PMlD: 14673387; http://dx.doi.org/l 0.1 097/00002281-200401000-00008.
66. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
67. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
68. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
69. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
70. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
71. Longo CR, Patel VI, Shrikhande GV, Scali ST, Csizmadia E, Daniel S, Sun DW, Grey ST, Arve MB, Ferran C. A20 protects mice from lethal radical hepatectomy by promoting hepatocyte proliferation via a p21wafl-dependent mechanism. Hepatology 2005; 42:156-64; PMTD:15962316; http://dx.doi. org/I 0.1 002/hep.20741.
72. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
73. Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Bioi 2010; 42:519-23; PMlD:20026420; http://dx.doi.org/1O.1016/j.bioceI.2009.12.016.
74. Damrauer SM, Fisher MD, Wada H, Siracuse n, da Silva CG, Moon K, Csizmadia E, Maccariello ER, Patel VI, Studer P, et al. A20 inhibits post-angioplasty restenosis by blocking macrophage trafficking and decreasing adventitial neovascularization. Atherosclerosis 201 0; 211:404-8; PMID:20430393; http://dx.doi.org/l 0.1 0 16/j.atherosclerosis.20 10.03.029.